Market Size of Global Escherichia Coli Testing Industry
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 1.36 Billion |
| Market Size (2029) | USD 2.00 Billion |
| CAGR (2024 - 2029) | 7.93 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Escherichia Coli Testing Market Analysis
The Global Escherichia Coli Testing Market size is estimated at USD 1.36 billion in 2024, and is expected to reach USD 2 billion by 2029, growing at a CAGR of 7.93% during the forecast period (2024-2029).
Escherichia coli are bacterium or germs that are commonly found in the environment, foods in the gut of humans and warm-blooded animals.
The COVID-19 pandemic had a significant impact on the market studied. As per the data from the National Institute of Health published in March 2022, according to evidence-based research and the concepts of antimicrobial stewardship, simultaneous infection of antibiotic-resistant uropathogens in patients with COVID-19 has forced a reconsideration of the administration of broad-spectrum antibiotics. According to a research article by Ahmed Al-Jabir et al., published in the International Journal of Surgery, July 2020, during the COVID-19 pandemic, urological procedures delayed or postponed included urinary tract infections, stress incontinence, overactive bladder (OAB), and neurogenic bladder. As urinary tract infection is caused by E. Coli, the diagnosis was delayed during the pandemic which affected the market growth.
Most of the Escherichia coli strains are harmless but some strains such as Shiga toxin-producing E.coli, can cause severe foodborne disease and are mostly transmitted through consumption of undercooked or raw ground meat products, raw milk, and contaminated raw vegetables and sprouts. Symptoms of the diseases caused by Shiga toxin-producing E.coli (STEC) include abdominal cramps, diarrhoea, bloody diarrhoea (haemorrhagic colitis), fever and vomiting.
In the case of water treatment plants, Escherichia coli is the test organism for finding out the effectiveness of the effluent disinfection treatment process. According to an article published in the Journal of Emerging Infectious Diseases in 2021, Escherichia coli accounts for over 85% of all urinary tract infections. The increasing prevalence of diarrhoea and high government funding are the key factors that drive the growth of the E. coli testing market.
Escherichia Coli Testing Industry Segmentation
As per the scope of the report, escherichia coli are species of bacteria that normally reside in the gastrointestinal tract as harmless normal flora; these rod-shaped bacteria commonly cause urinary tract infections, and some strains produce toxins that cause diarrheal disease. The Escherichia Coli Testing Market is Segmented By Test (Clinical Testing (Polymerase Chain Reaction, Enzyme Immunoassays), Environmental Testing (Membrane Filtration, Multiple Tube Fermentation, Enzyme Substrate Method)), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Test | |||||
| |||||
|
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Escherichia Coli Testing Market Size Summary
The Escherichia coli testing market is poised for significant growth over the forecast period, driven by the increasing prevalence of foodborne illnesses and urinary tract infections caused by various strains of E. coli. The market is influenced by the need for effective testing methods to ensure food safety and public health, particularly in regions with high incidence rates of infections. The COVID-19 pandemic has impacted the market by delaying diagnoses and procedures related to E. coli infections, but it has also highlighted the importance of antimicrobial stewardship and advanced testing technologies. The polymerase chain reaction (PCR) technique is gaining traction for its ability to accurately detect E. coli and other pathogens, contributing to the market's expansion.
North America is expected to dominate the global E. coli testing market, supported by high infection rates and increased awareness of hygiene practices. The region benefits from advanced testing technologies and significant government investment in public health initiatives. The presence of major market players and ongoing research and development efforts further bolster the market's growth prospects. Companies like Thermo Fisher Scientific, BioMerieux Inc, and Becton, Dickinson and Company are key contributors to the market, offering innovative solutions for E. coli detection and testing. As the demand for reliable testing methods continues to rise, the market is set to experience robust growth, with North America leading the charge.
Global Escherichia Coli Testing Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Prevalence of Diarrhoea
-
1.2.2 New Technological Advancements
-
-
1.3 Market Restraints
-
1.3.1 High Cost of E. coli Treatment
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size - Value in USD million)
-
2.1 By Test
-
2.1.1 Clinical Testing
-
2.1.1.1 Polymerase Chain Reaction
-
2.1.1.2 Enzyme Immunoassays
-
-
2.1.2 Environmental Testing
-
2.1.2.1 Membrane Filtration
-
2.1.2.2 Multiple Tube Fermentation
-
2.1.2.3 Enzyme Substrate Method
-
-
-
2.2 Geography
-
2.2.1 North America
-
2.2.1.1 United States
-
2.2.1.2 Canada
-
2.2.1.3 Mexico
-
-
2.2.2 Europe
-
2.2.2.1 Germany
-
2.2.2.2 United Kingdom
-
2.2.2.3 France
-
2.2.2.4 Italy
-
2.2.2.5 Spain
-
2.2.2.6 Rest of Europe
-
-
2.2.3 Asia-Pacific
-
2.2.3.1 China
-
2.2.3.2 Japan
-
2.2.3.3 India
-
2.2.3.4 Australia
-
2.2.3.5 South Korea
-
2.2.3.6 Rest of Asia-Pacific
-
-
2.2.4 Middle-East and Africa
-
2.2.4.1 GCC
-
2.2.4.2 South Africa
-
2.2.4.3 Rest of Middle-East and Africa
-
-
2.2.5 South America
-
2.2.5.1 Brazil
-
2.2.5.2 Argentina
-
2.2.5.3 Rest of South America
-
-
-
Global Escherichia Coli Testing Market Size FAQs
How big is the Global Escherichia Coli Testing Market?
The Global Escherichia Coli Testing Market size is expected to reach USD 1.36 billion in 2024 and grow at a CAGR of 7.93% to reach USD 2.00 billion by 2029.
What is the current Global Escherichia Coli Testing Market size?
In 2024, the Global Escherichia Coli Testing Market size is expected to reach USD 1.36 billion.
